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Abstract
Background: Although traditional forms of therapy for anxiety-related disorders (eg, cognitive behavioral therapy, CBT) have
been effective, there have been long-standing issues with these therapies that largely center around the costs and risks associated
with the components comprising the therapeutic process. To treat certain types of specific phobias, sessions may need to be held
in public, therefore risking patient confidentiality and the occurrence of uncontrollable circumstances (eg, weather and bystander
behavior) or additional expenses such as travel to reach a destination. To address these issues, past studies have implemented
virtual reality (VR) technologies for virtual reality exposure therapy (VRET) to provide an immersive, interactive experience that
can be conducted privately and inexpensively. The versatility of VR allows various environments and scenarios to be generated
while giving therapists control over variables that would otherwise be impossible in a natural setting. Although the outcomes
from these studies have been generally positive despite the limitations of legacy VR systems, it is necessary to review these studies
to identify how modern VR systems can and should improve to treat disorders in which anxiety is a key symptom, including
specific phobias, posttraumatic stress disorder and acute stress disorder, generalized anxiety disorder, and paranoid ideations.
Objective: The aim of this review was to establish the efficacy of VR-based treatment for anxiety-related disorders as well as
to outline how modern VR systems need to address the shortcomings of legacy VR systems.
Methods: A systematic search was conducted for any VR-related, peer-reviewed articles focused on the treatment or assessment
of anxiety-based disorders published before August 31, 2017, within the ProQuest Central, PsycINFO, and PsycARTICLES
databases. References from these articles were also evaluated.
Results: A total of 49 studies met the inclusion criteria from an initial pool of 2419 studies. These studies were a mix of case
studies focused solely on VRET, experimental studies comparing the efficacy of VRET with various forms of CBT (eg, in vivo
exposure, imaginal exposure, and exposure group therapy), and studies evaluating the usefulness of VR technology as a diagnostic
tool for paranoid ideations. The majority of studies reported positive findings in favor of VRET despite the VR technology’s
limitations.
Conclusions: Although past studies have demonstrated promising and emerging efficacy for the use of VR as a treatment and
diagnostic tool for anxiety-related disorders, it is clear that VR technology as a whole needs to improve to provide a completely
immersive and interactive experience that is capable of blurring the lines between the real and virtual world.
(JMIR Serious Games 2018;6(4):e10965)   doi:10.2196/10965
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Introduction
Background
Anxiety-related disorders such as specific phobias, posttraumatic
stress disorder (PTSD), and general or specific anxiety (eg,
public speaking or social anxiety) disorders stand as 1 of the
most common, growing mental health disorders worldwide [1].
In 2014, 19.5% of individuals above the age of 16 years had
shown signs of anxiety or depression, with the United Kingdom
alone experiencing a 1.5% increase from 2013 [1]. To combat
the symptoms of anxiety-related disorders, 1 of the most
effective treatment methods has been exposure therapy, which
stems from the broader practice of cognitive behavioral therapy
(CBT) [2]. In exposure therapy, patients undergo a process of
systematic desensitization, where a series of systematic steps
are employed to gradually expose the patient to an anxiety- or
fear-inducing stimulus, with the ultimate goal of minimizing
the patient’s intense and adverse behavior toward the stimulus.
Furthermore, the therapists may employ methods to change the
patient’s cognitions about the stimulus, such as through
psychoeducation, to reinforce treatment gains from systematic
desensitization [3].
Traditionally, stimuli in exposure therapy are presented through
in vivo exposure (IVE) or imaginal exposure (IE), each of which
carries its own set of advantages and disadvantages. IVE
involves live exposure to the stimuli, often being utilized to
treat specific phobias or anxieties such as arachnophobia (fear
of spiders) [4], acrophobia (fear of heights) [5], and social
anxiety [6]. Although IVE is considered to be the most effective
method for helping the patient overcome their anxiety or fear,
disorders such as aviophobia (fear of flying) and social anxiety
may require sessions to be conducted in public, therefore posing
a risk of breaking patient confidentiality; become too expensive
to perform single or repeated exposure sessions; and introduce
uncontrollable variables that may hinder the overall treatment
(eg, behavior of living organisms and weather conditions) [7-9].
Even if these issues can be addressed, some individuals may
feel that confronting an anxiety- or fear-inducing stimulus may
be too aversive, which may lead to participants dropping out of
treatment or not seeking treatment at all [5]. IE can address
many of the limitations of IVE, as patients are tasked with
generating the stimulus in his or her imagination rather than
confronting a live version of the stimulus; however, the patient
may be potentially unable or unwilling to generate a vivid
imaginal representation of the stimulus [10].
Since the early to mid-1990s, therapists have attempted to seek
an alternative to IVE and IE through the use of virtual reality
(VR) technologies through a process known as virtual reality
exposure therapy (VRET). VR technology includes a wide range
of configurations, including head-mounted displays (HMDs),
external projection setups such as the CAVE Automatic Virtual
Environment [11], and simulators [12], all of which vary in
terms of technical specifications (eg, display resolution, tracking
accuracy, and field of view). Regardless of the form of VR,
VRET generally follows the same treatment protocols as
traditional exposure therapy but renders the anxiety or
fear-inducing stimulus within a virtual environment that
immerses the user with sensory stimuli. These stimuli are often
limited to the user’s visual and auditory senses but may
sometimes incorporate tactile stimuli through an apparatus (eg,
force feedback gloves, toy spiders) to allow VR users to feel
objects with their hands. By utilizing a customizable virtual
environment, VRET offers an unparalleled level of control for
the therapist to manipulate factors that could not be controlled
in a standard IVE session and tailor the sessions based on the
patient’s needs—all in the confines of the therapist’s office
[9,13].
Despite a major interest in VR during its inception, VR was
often expensive, uncomfortable, and required special training
to operate. The computers used to run VR were barely able to
do so, leading to low-quality VR experiences (eg, jagged
graphics and inconsistent and low frame rates) that could lead
to simulator sickness, characterized by symptoms of nausea,
headaches, and dizziness [6]. In addition to simulator sickness,
early HMDs were also heavy, resulting in users experiencing
neck pain after prolonged use. Furthermore, without adequate
software distribution systems to sell or share VR programs,
special training would often be required to create VR programs
to suit the research or therapists’ needs. These limitations
ultimately restricted the use and research of VR-based
psychotherapy to well-funded or specialized institutions [14].
Although early VR technologies have been largely inaccessible
to a mass audience, recent developments in VR technologies
have addressed many of the issues that plagued legacy units.
Both the HTC Vive and Oculus Rift, which released in 2016,
were lighter and powerful enough to render high-quality visual
and auditory stimuli. Both HMDs were also integrated with
major digital distribution services such as Steam, which has
attracted both small, independent developers and large,
professional developers alike to create high-quality VR
programs. Renewed interest in VR also led to a push for mobile
VR, a less powerful yet inexpensive version of computer-based
VR that could run on modern mobile phones (e.g. iPhone,
Google Pixel, etc.).
Objective
The aim of this systematic review was to explore previously
established VR studies within psychotherapy to inform future
VR research. Although modern VR HMDs are still relatively
new, evaluating how past studies have utilized the VR
technologies of their era can serve as a comprehensive guide as
to how VR-based psychotherapy programs can improve in the
future as well as whether the limitations observed in past studies
are still relevant with the current iteration of VR systems. Topics
covered in this review will mainly cover the efficacy of VRET
treatment, its uses as a diagnostic or assessment tool, and
innovations in the pursuit of greater VR experiences in relation
to psychological disorders in which anxiety is a key symptom,
including specific phobias, PTSD and acute stress disorder
(ASD), specific and general anxiety disorder, and paranoid
ideations.
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Methods
Databases Searched
ProQuest Central, PsycINFO, and PsycARTICLES were the
databases used to conduct a comprehensive search of the past
literature. Studies must have been published before August 31,
2017, peer-reviewed, published in a scholarly journal, written
in English, and have full-text availability.
Search Terms
The command line used for the search was as follows: “virtual
reality” AND (phobia OR anxiety) AND (treatment OR therapy).
Although VR is a common referential acronym for virtual
reality, the full term was exclusively used during the search to
streamline the search process and avoid any other terms that
may use the VR acronym (eg, variable reward and voice
recognition). An initial 2419 studies were collected from the 3
databases used to conduct this search.
Figure 1. Systematic Review Search Prisma. HMD: head-mounted display; VR: virtual reality.
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Table 1. Specific phobia treatments.
Intervention (patients, n)Follow-upSession lengthSessions, nMethodologyPhobia typeAuthor
VRETa (n=1)1 month35-45 min8CaseClaustrophobiaBotella et al [17]
VRET (n=12); IVEb (n=12);
WLc (n=13)
12 months1 hour9ControlledAgoraphobiaBotella et al [18]
VRET (n=1)None50 min12CaseArachnophobiaCarlin et al [9]
VRET (n=17); IVE (n=16)6 months1 hour3ControlledAcrophobiaEmmelkamp et al [19]
VRET (n=12); WL (n=11)None1 hour3-10 (4)dControlledArachnophobiaGarcia-Palacios et al [7]
VRET (n=20); EGTe (n=23)6 months50 min5ControlledAviophobiaMaltby et al [13]
VRET (n=16); WL (n=16)None60 min1ControlledMultipleMoldovan and David [20]
VRET (n=15); RTf (n=13)None180 min1ControlledAviophobiaMuhlberger et al [8]
VRET (n=12); WL (n=8)None35-45 min7ControlledAcrophobiaRothbaum et al [21]
VRET (n=1)None35-45 min5CaseAcrophobiaRothbaum et al [22]
VRET (n=1)1 month35-45 min6CaseAviophobiaRothbaum et al [23]
VRET (n=15); IVE (n=15); WL
(n=15)
6 months1 hour8ControlledAviophobiaRothbaum et al [24]
VRET (n=13); IVE (n=11)12 months1 hour8ControlledAviophobiaRothbaum et al [25]
VRET (n=25); IVE (n=25); WL
(n=25)
6 and 12
months
N/Ag8ControlledAviophobiaRothbaum et al [26]
MCEh VRET (n=15); SCEi
VRET (n=15)
NoneN/A2ControlledArachnophobiaShiban et al [27]
VRET+VPTj (n=1)NoneN/A8CaseAcrophobiaWhitney et al [28]
aVRET: virtual reality exposure therapy.
bIVE: in vivo exposure.
cWL: waiting list.
dMean value.
eEGT: exposure group therapy.
fRT: relaxation therapy.
gN/A: not applicable.
hMCE: multiple context exposure.
iSCE: single context exposure.
jVPT: vestibular physical therapy.
Inclusion and Exclusion Criteria
For the initial 2419 studies collected, the following inclusion
and exclusion criteria were implemented. Parameters were set
to limit the studies only to those whose subject was on VR
(n=217) and whose document type was either an article or a
case study (n=203). Studies that did not perform an experiment
using an HMD for treating or examining a specific phobia or
anxiety were excluded (n=177) as were other systematic reviews
or meta-analyses (n=3). HMDs were chosen as the VR system
of choice for this review as the systems were the most accessible
compared with CAVE and simulator-type systems, alongside
the notion that the most prominent modern VR systems are
HMDs. In total, 23 eligible studies met the inclusion criteria.
Another search was conducted based on the references detailed
in each of the initial 23 eligible studies. Inclusion criteria for
this search were that the reference title must have mentioned
“virtual reality” alongside terms related to fear, anxiety, or a
specific phobia, as well as having explicitly used an HMD within
the study itself. A total of 27 additional studies were collected
through these criteria, although 1 study appeared to have been
published twice in 2 years with some minor differences;
therefore, the most recent version of that study was kept [15],
whereas the older version was excluded [16], resulting in only
26 additional studies. In total, 49 studies were examined for this
review.
Information found in Figure 1 exhibits the process in which the
studies in this review were obtained based on the inclusion
criteria as well as the number of studies excluded based on the
initial exclusion criteria.
Studies were also placed into 1 of the 5 categories for the
purposes of this review: phobia treatments (see Table 1), PTSD
treatments (see Table 2), anxiety treatments (see Table 3),
paranoia evaluation (see Table 4), and innovations and
evaluation (see Table 5).
JMIR Serious Games 2018 | vol. 6 | iss. 4 | e10965 | p.4http://games.jmir.org/2018/4/e10965/
(page number not for citation purposes)
Oing & PrescottJMIR SERIOUS GAMES
XSL•FO
RenderX
Quality Assessment
Quality assessment of the collected studies was examined by
both authors using the inclusion and exclusion criteria. The
quality of each of the 49 studies was also appraised through the
mixed methods appraisal tool (2011), which was designed to
assess the methodological quality of quantitative (randomized,
nonrandomized, and descriptive), qualitative, and
mixed-methods studies used within systematic reviews [60].
Table 2. Posttraumatic stress disorder and acute stress disorder treatments.
Interventions and patients, nFollow-upTrauma typeStudy typeAuthor
VRETa (n=1)NoneWarCaseGerardi et al [29]
VRET (n=6)NoneAssaultUncontrolledCardenas-Lopez et al [30]
VRET (n=10); TAUb (n=10)NoneWarControlledMcLay et al [31]
VRET (n=24)NoneWarUncontrolledReger et al [32]
VRET (n=54); IEc (n=54) ; MAd (n=54)3 and 6 monthsWarControlledReger et al [33]
VRET (n=1)NoneAssaultCaseCardenas Lopez and de la Rosa-Gomez [34]
VRET (n=1)3 and 6 monthsWarCaseRothbaum et al [35]
VRET with D-cycloserine (n=53); VRET
with alprazolam (n=50); VRET with
placebo (n=53)
3, 6, and 12 monthsWarControlledRothbaum et al [36]
aVRET: virtual reality exposure therapy.
bTAU: treatment as usual.
cIE: imaginal exposure.
dMA: minimal attention.
Table 3. Anxiety treatments.
Comparisons and patients, nFollow-upSession lengthSessions, nStudy typeAnxiety typeAuthor
High test anxiety (n=11); Low test
anxiety (n=10)
None90 min1UncontrolledPerformanceAlsina-Jurnet et al [37]
VRETa (n=2)UnknownUnknown6 to 10Case studySocialAnderson et al [38]
VRET (n=25); EGTb (n=25); WLc
(n=25)
3 and 12
Months
Unknown8ControlledSocialAnderson et al [6]
VRET (n=8); WL (n=6)None12-15 min/exposure4ControlledSocialHarris et al [39]
VRd exposure first half (n=15); VR
exposure second half (n=15)
UnknownUnknown1ControlledDentalPadrino-Barrios et al [40]
VRET with biofeedback (n=9);
VRET without biofeedback (n=8);
WL (n=8)
UnknownUnknown8ControlledGeneralRepetto et al [41]
Active VR (n=22); Passive VR
(n=23); No VR (n=24)
1 weekUnknown1ControlledDentalTanja-Dijkstra et al [42]
VRET (n=28); CBTe (n=30); WL
(n=30)
None1 hour12ControlledSocialWallach et al [43]
aVRET: virtual reality exposure therapy.
bEGT: exposure group therapy.
cWL: waiting list.
dVR: virtual reality.
eCBT: cognitive behavioral therapy.
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Table 4. Paranoia or paranoid ideations evaluation.
AnalysisAge in years, mean (SD)Pateints, nAuthor and population
QualitativeFornells-Ambrojo et al [44]
24.2 (2.3)10Early psychosis (clinical)
23.8 (2.3)10Healthy (Nonclinical)
Quantitative34.4 (11.6)106Freeman et al [45]: Assaulted 1 month before
Quantitative37.5 (13.3)200Freeman et al [46]: Local adult
QuantitativeFreeman et al [47]
44.2 (11.2)30Low nonclinical paranoia
36.0 (11.7)30High nonclinical paranoia
44.2 (11.7)30Persecutory delusions
Table 5. Virtual reality evaluations and innovations.
AimDisorderAuthor
Evaluating the relationship between trait social anxiety and startle reactivitySocial anxietyCornwell et al [48]
Assessing perceptual estimates and actions of gaps within VRaAcrophobiaGeuss et al [49]
Evaluating the efficacy of various social stressors within VRSocial anxietyHartanto et al [50]
Assessing effects of VR exposure on performing musiciansPerformance anxietyOrman [51]
Evaluating the efficacy of VR stimuli for social anxiety VRETbSocial anxietyOwens and Beidel [52]
Assess the virtual interactions of patients with schizophrenia with digital avatarsSocial anxietyPark et al [53]
Evaluate participant responses toward positive, negative, and static virtual audiencesPublic speaking anxietyPertaub et al [15]
Evaluate a VR-based interactive dialogue system to elicit the same level of fear from an in vivo
conversation
Social anxietyPowers et al [54]
Evaluate the importance of presence within VR as a predictor of treatment response for social
anxiety VRET
Social phobiaPrice et al [55]
Evaluate the influence of virtual bystanders on the participant’s self-efficacy, anxiety, social
evaluation, vicarious experience, and cognitive consistency
Social phobiaQu et al [56]
Assessing the relationship between presence and fear of heights within VRAcrophobiaRegenbrecht et al [57]
Assessing the efficacy of low-fidelity VR on social anxiety VRETSocial anxietySlater et al [58]
Evaluate the effects of childhood trauma on social stress reactivity and psychopathology within
VR
Social anxietyVeling et al [59]
aVR: virtual reality.
bVRET: virtual reality exposure theory.
Results
Quality Assessment Outcomes
The 49 studies received an average rating of 86.73% and a modal
rating of 100% (n=30). A total of 10 studies were classified as
qualitative, 21 studies as quantitative randomized, 15 studies
as quantitative nonrandomized, and 3 studies as quantitative
descriptive based on the parameters set by the mixed methods
appraisal tool [60].
Summary of Papers
Specific Phobias
The implementation of VRET for the treatment of specific
phobias typically mirrors traditional phobia treatment protocols;
treatment rationale was explained upon or before the patient’s
arrival, information-gathering procedures were used to assess
the patient’s phobic level, and a stimulus hierarchy would be
established based on the information gathered. Levels of the
stimulus hierarchy would vary based on the phobia being treated
but generally would incorporate a new level or factors as the
patient progresses. For example, acrophobia patients undergoing
VRET would often progress through greater heights [19,21,22],
whereas aviophobia patients would experience the next stage
of a flight (eg, stationary and take-off) [8,23,24,26]. In short,
regardless of the research methodology used or the specific
phobia examined, treatment procedures were consistent across
the 16 specific phobia studies.
A few studies compared the efficacy of VRET with that of a
pre-established treatment including standard IVE [18,19,24],
relaxation therapy [8], or exposure group therapy [13]. In 1
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study comparing treatment outcomes of VRET, IVE, and a
waiting list condition for participants with agoraphobia, no
significant differences were observed at the posttreatment and
12-month follow-up assessments between those that underwent
VRET or IVE, but both groups did demonstrate significant
improvements over those in the waiting list condition [18]. The
comparison for VRET and relaxation therapy yielded similar
results; however, it was found that although VRET was more
effective in reducing flying avoidance in participants, it was
only marginally better at reducing the participants’ fear of flying
ratings compared with relaxation therapy [8]. Finally, in a
comparison of VRET and exposure group therapy, more VRET
participants experienced clinically significant change compared
with exposure group therapy participants based on posttreatment
assessments, but the significant difference disappeared between
the 2 groups during the 6-month follow-up [13].
Posttraumatic Stress Disorder and Acute Stress Disorder
Studies investigating the efficacy of VRET on PTSD and ASD
typically focused on patients who developed the disorder due
to wartime combat or physical assault. Initial sessions followed
the same format and components as the ones used for specific
phobias, but VRET sessions were more personalized for each
patient. For example, veterans were given a virtual environment
that matched the war environment that they had participated in,
which included a jungle for the Vietnam War [35] and a desert
city for Middle Eastern wars [29,31-33,36]; victims of physical
abuse unrelated to war were placed in an urban environment
[30,34].
A comparison of VRET, IE, and waiting list conditions found
that, although VRET and IE both led to significant
improvements in PTSD symptoms compared with the waiting
list, IE was superior based on the Clinician-Administered PTSD
Scale (CAPS), a structured interview performed by the clinician
to gauge the severity of PTSD-related symptoms [61]. Follow-up
assessments conducted at 3 and 6 months also indicated that
those who underwent IE experienced continual improvement,
whereas those who underwent VRET did not [33].
Another study sought to compare VRET with a
treatment-as-usual condition, which consisted of patients
performing their pre-established treatments, which included or
was a combination of prolonged exposure, eye movement
desensitization and reprocessing, and group therapy. A
posttreatment assessment using CAPS indicated that 70% (7/10)
of patients that underwent VRET showed at least a 30%
improvement, whereas only 11% (1/9) of treatment-as-usual
patients showed the same level of improvement. Although this
difference was deemed as significant, the authors noted that a
small sample size and wide variability in the treatment-as-usual
condition limited the interpretations of the study’s outcomes
[31].
Finally, 1 study investigated whether augmenting VRET with
D-cycloserine, a glutamate receptor that had been demonstrated
to improve the efficacy of exposure therapy for severe anxiety
disorders, would also benefit VRET. All participants in the
study underwent VRET but were given D-cycloserine,
alprazolam (used primarily as a pharmacological treatment for
anxiety), or a placebo pill. The study reported no significant
differences in treatment outcomes for any of the groups based
on CAPS scores; however, participants who were dosed with
D-cycloserine experienced significant extinction learning that
was not observed in the alprazolam and placebo groups,
suggesting that the use of D-cycloserine helped to enhance
learning effects during VRET [36].
Anxiety
Studies that focused on general or specific (social, public
speaking, dental, or test) anxiety utilized VR as a method to
deliver VRET or VR distraction interventions. Although VRET
for general and specific anxiety largely mirrored the same
procedural format as the VRET done for specific phobias, PTSD,
and ASD, VR distraction was used to comfort patients during
a dental procedure. Although VRET aims to address problematic
behaviors and cognitions by exposing patients to a virtual
simulation, VR distraction serves to give patients a more positive
experience during an otherwise anxiety-inducing situation [40].
A comparison was conducted for the efficacy of VRET to CBT
and waiting list conditions for the treatment of public speaking
anxiety, and findings were largely concurrent with the specific
phobia studies; both treatment groups experienced significant
improvements over the waiting list, but did not significantly
differ with each other based on posttreatment assessments [43].
A similar finding was reported when VRET was compared with
EGT as an intervention for public-speaking anxiety across
posttreatment, 3-month, and 12-month follow-up assessments;
however, the study had a small sample size that limited the
findings [6].
A study that evaluated VRET for the treatment of general
anxiety disorder incorporated biofeedback and a mobile, rather
than a computer-based, VR system. The virtual environments
for the biofeedback group, which depicted various scenes
associated with relaxation, could change based on the patient’s
heart rate and physiological activation; a reduction in either
results in a reduced intensity for certain stimuli within the virtual
environment. Virtual environments for the VRET without
biofeedback and waiting list groups experienced the same scenes
but without the additional biofeedback features. Those who
were in the biofeedback group were reported to have a
significant decrease in behavioral avoidance and state anxiety,
whereas the VR without biofeedback group only experienced
a significant decrease in behavioral avoidance, and the waiting
list group experienced no significant changes [41].
VR distraction was utilized for both dental anxiety studies in
this review, which were conducted during either a simulated
[40] or live [42] procedure. The stimulated dental procedure
study compared active VR, passive VR, and no VR; those in
the active VR condition could freely navigate around the virtual
environment, whereas those in the passive VR condition could
not. Those with higher levels of dental anxiety in both the active
and passive VR conditions were reported to have less vivid
memories of the procedure compared with those that completed
the procedure without VR [40]. Similar findings were reported
for the live procedure study in which an oral prophylaxis (teeth
cleaning) was performed. Participants were randomly assigned
to 1 group that received VR distraction during the first half of
the procedure and another group that received the VR distraction
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during the second half. Participants in both groups experienced
significantly greater calmness during the portion of the
procedure when they received VR distraction compared with
the portion when they did not [42].
Paranoia or Paranoid Ideations
The process of diagnosing paranoia has been difficult to do in
real settings, as therapists must be able to discern whether an
individual’s claims are legitimate or based on true paranoid
beliefs. Through the use of VR, the diagnostic process for
paranoia can be more reliable as the therapist has more control
over the virtual stimuli, environment, and situational factors;
avatars in the virtual environment cannot physically harm nor
be harmed by the patient, and paranoid beliefs that surface
during VR exposure can be verified [47]. As there were not a
lot of studies dedicated to this topic, each study employed the
same task within the same virtual environment: participants
rode a London Underground train for a few minutes surrounded
by avatars with neutral expressions and mannerisms.
In 1 study, individuals were found to be twice as likely to
experience some form of persecutory thoughts during VR
exposure if they reported paranoid ideations in day-to-day life
[46]. This finding provided support toward the notion that
neutral avatars were capable of eliciting paranoid thoughts,
which was further confirmed in another study that compared
the reactions of individuals belonging to clinical paranoia, high
nonclinical paranoia, and low nonclinical paranoia groups [47].
Innovations and Evaluations
Although previous sections covered how VR has been used to
treat or study certain anxiety-based disorders, it is worth noting
the studies that have sought to either study VR-specific features
or create innovative programs to enhance VR-based treatment.
For example, an interactive dialogue system for a study on social
anxiety was developed to elicit fear responses during VR
exposure to match the fear response levels observed in in vivo
conversations. Although the study reported that participants
believed in vivo conversations were more realistic than the ones
held in VR, fear ratings were found to be significantly higher
for VR conversations than for in vivo ones. Although realism
is an important factor, the authors considered that fear was a
more important factor in the context of treating symptoms of
social anxiety [54].
Another study sought to use dynamic social dialogue systems
to manipulate the participant’s feelings of anxiety in real time
and effectively demonstrated that different ratios of positive
and negative responses could serve as effective anxiety stressors
to manipulate the participant’s anxiety level in any direction
(low to high) at any time [50]. Other studies aimed to evaluate
changes in audience behaviors and other social stressors (eg,
number of avatars present and ethnic diversity) and demonstrated
similar levels of efficacy in manipulating the patient’s anxiety
levels [52,59].
Several studies were also conducted to evaluate whether VR
stimuli were capable of eliciting real emotions, a crucial factor
for the treatment and assessment of specific phobias and other
anxiety disorders. There are some mixed findings; although a
study on acrophobia found evidence that participants
experienced real fear when exposed to a virtual cliff [57], a
study on woodwind performance anxiety found inconsistencies
in subjective anxiety ratings during a performance in a virtual
concert hall [51]. For the latter, the authors speculated that an
increase in heart rate during VR exposure may have been due
to the nature of performing on a wind instrument rather than
due to the VR exposure, and the inconsistent subjective anxiety
ratings could have been due to performers finding the act of
performing to be psychologically calming rather than
anxiety-inducing.
Discussion
Principal Findings
In relation to VRET, there appears to be an overwhelming
amount of positive evidence that the VR-based treatment has
an equal or greater efficacy toward the treatment of specific
phobias and anxiety, but not as much for PTSD and ASD. This
evidence comes from a mix of experimental designs, including
case studies, controlled randomized trials, and within-group
designs, with some studies also offering follow-up results as
evidence of VRET’s effects beyond posttreatment. Although
the use of VRET for PTSD and ASD was effective, it appeared
that some patients seemed to gain continual improvement when
treated with another treatment option such as IE [33].
Regardless, those who underwent VRET consistently showed
significant improvement over those in the waiting list groups
in the specific phobia, specific anxiety, and PTSD and ASD
studies that compared the 2 together.
The use of VR to aid in the diagnosis of paranoia was also
largely shown to be effective and was further reinforced due to
every study related to the topic in this review using the same
procedures and virtual environment to study or differentiate
between individuals with varying levels of paranoia. Although
VR was not used as a treatment tool for paranoia, it does provide
a safe environment for the patient while simultaneously giving
therapists and researchers a way to accurately identify any
paranoid ideations that may arise due to VR exposure.
Finally, there have been many innovations to bolster the user’s
sense of immersion, or the feeling of being present, within an
environment afforded by VR technology, at least for programs
focused on treating social anxiety disorders. These innovations
were largely focused on making VR avatars more realistic and
sociable, ranging from increasing the realism of a
person-to-avatar conversation to the manipulative behaviors of
multiple avatars that comprise a virtual audience. In general,
these innovations achieved their purpose by eliciting a greater
amount of fear within the participant [54] or providing a
dynamic manipulation of participant anxiety levels [50,52,59].
As for the evaluation of VR elements, simply recreating an
object that the participant fears, such as a virtual cliff for those
with acrophobia [57], is enough to generate real fear, although
testing VR’s efficacy on some tasks, such as performing on a
woodwind instrument [51], may prove to be difficult due to the
nature of the task itself and how it may conflict with common
psychological or biometric measures.
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Limitations
Although a large number of studies were included in this review,
some topics appeared to be more researched than others, thus
providing varying levels of quality and quantity. In particular,
there were a small number of studies dedicated to paranoia, and
although every study included in this review related to paranoia
utilized the same virtual environments and procedures, the
results may have been strengthened with more variety in the
types of virtual environments used beyond the London
Underground.
This issue also persists for the specific anxiety and PTSD and
ASD studies in this review, where there was 1 clear subject that
dominated, whereas there were only a few studies that ventured
beyond what was commonly researched. For specific anxiety,
there were more studies focused on social or public speaking
anxiety, with only a couple of studies focused on dental anxiety,
and the PTSD and ASD studies largely focused on war-induced
trauma rather than physical assault–induced trauma.
Future Research
The landscape of modern VR has changed drastically compared
with the VR systems used in most of the studies included in this
review. Although legacy VR systems were expensive, required
users to receive special training to operate or create VR
programs, and were limited to facilities that could invest in the
technology, modern VR has provided cheaper entry points, a
vast library accessible through popular digital storefronts such
as Steam or Google Play and Apple App Store, and user-friendly
experiences. Although the most powerful VR systems available
today are mostly geared toward gaming, the same systems can
provide some use toward the study, diagnosis, or treatment of
various anxiety-based disorders.
One area of research that would be worth pursuing is a
self-directed rendition of VRET that can be done within a
patient’s home with little to no therapist interaction. As there
is an overwhelming amount of positive evidence toward the
efficacy of VRET, at least in relation to specific phobias and
anxieties, the next step toward evolving VRET may be to
evaluate whether those with mild to moderate anxiety-based
systems may benefit from merely exposing themselves to
anxiety-inducing stimuli within a virtual environment. Self-
directed interventions provide patients with care in areas with
limited to no access to therapists as well as to those who may
be reluctant to see a therapist [62]. By utilizing a self-directed
approach to VRET, it may be possible to allow individuals with
low anxiety severity to treat themselves at their own pace, within
their own home, and without the need for a therapist.
Conclusions
This review evaluated a variety of topics related to the use of
VR for anxiety-based disorders, including VRET for specific
phobias, specific anxieties, PTSD and ASD, and paranoia, while
also outlining various innovations and evaluations conducted
by studies to either improve the experiences afforded by VR or
investigate the various factors that contribute to its efficacy
toward anxiety-based treatments. These studies provided
generally positive evidence toward the diagnostic and treatment
capabilities of VR for anxiety-based disorders; however,
research into VR has generally been limited to institutions that
had the resources to invest in it. With the advent of more
affordable, user-friendly, and supported commercial VR
systems, more VR research can finally be done by building on
the foundation laid out by the early studies to both replicate past
findings and establish new uses for VR within psychotherapy.
 
Conflicts of Interest
None declared.
References
1. Mental Health Foundation. Fundamental Facts About Mental Health. London: Mental Health Foundation; 2016.
2. López GC, Gómez AR, Figueroa RD, Baca XD. Virtual reality exposure for trauma and stress-related disorders for city
violence crime victims. Int J Child Health Hum Dev 2016;9(3):315-322 [FREE Full text]
3. Hoffman HG, Garcia-Palacios A, Carlin A, Furness TA, Botella-Arbona C. Interfaces that heal: coupling real and virtual
objects to treat spider phobia. Int J Hum Comput Interact 2003;16(2):283-300. [doi: 10.1207/S15327590IJHC1602_08]
4. Wrzesien M, Burkhardt JM, Alcañiz M, Botella C. How technology influences the therapeutic process: a comparative field
evaluation of augmented reality and in vivo exposure therapy for phobia of small animals. : Springer; 2011 Presented at:
IFIP TC 13 International Conference on Human-Computer Interaction; September 2011; Lisbon, Portugal p. 523-540. [doi:
10.1007/978-3-642-23774-4_43]
5. Emmelkamp PM, Bruynzeel M, Drost L, van der Mast CA. Virtual reality treatment in acrophobia: a comparison with
exposure in vivo. Cyberpsychol Behav 2001 Jun;4(3):335-339. [doi: 10.1089/109493101300210222] [Medline: 11710257]
6. Anderson PL, Price M, Edwards SM, Obasaju MA, Schmertz SK, Zimand E, et al. Virtual reality exposure therapy for
social anxiety disorder: a randomized controlled trial. J Consult Clin Psychol 2013 Oct;81(5):751-760. [doi:
10.1037/a0033559] [Medline: 23796315]
7. Garcia-Palacios A, Hoffman H, Carlin A, Furness TA, Botella C. Virtual reality in the treatment of spider phobia: a controlled
study. Behav Res Ther 2002 Sep;40(9):983-993. [Medline: 12296495]
8. Mühlberger A, Herrmann MJ, Wiedemann GC, Ellgring H, Pauli P. Repeated exposure of flight phobics to flights in virtual
reality. Behav Res Ther 2001 Sep;39(9):1033-1050. [doi: 10.1016/S0005-7967(00)00076-0] [Medline: 11520010]
9. Carlin AS, Hoffman HG, Weghorst S. Virtual reality and tactile augmentation in the treatment of spider phobia: a case
report. Behav Res Ther 1997 Feb;35(2):153-158. [doi: 10.1016/S0005-7967(96)00085-X] [Medline: 9046678]
JMIR Serious Games 2018 | vol. 6 | iss. 4 | e10965 | p.9http://games.jmir.org/2018/4/e10965/
(page number not for citation purposes)
Oing & PrescottJMIR SERIOUS GAMES
XSL•FO
RenderX
10. Wiederhold BK, Jang DP, Gevirtz RG, Kim SI, Kim IY, Wiederhold MD. The treatment of fear of flying: a controlled
study of imaginal and virtual reality graded exposure therapy. IEEE Trans Inf Technol Biomed 2002 Sep;6(3):218-223.
[doi: 10.1109/TITB.2002.802378] [Medline: 12381038]
11. Cruz-Neira C, Sandin D, DeFanti T. Surround-screen projection-based virtual reality: the design and implementation of
the CAVE. 1993 Presented at: The 20th annual conference on computer graphics interactive techniques; 1993; New York
p. 135-142.
12. Mühlberger A, Bülthoff HH, Wiedemann G, Pauli P. Virtual reality for the psychophysiological assessment of phobic fear:
responses during virtual tunnel driving. Psychol Assess 2007 Sep;19(3):340-346. [doi: 10.1037/1040-3590.19.3.340]
[Medline: 17845125]
13. Maltby N, Kirsch I, Mayers M, Allen GJ. Virtual reality exposure therapy for the treatment of fear of flying: a controlled
investigation. J Consult Clin Psychol 2002 Oct;70(5):1112-1118. [doi: 10.1037/0022-006X.70.5.1112] [Medline: 12362961]
14. Lindner P, Miloff A, Hamilton W, Reuterskiöld L, Andersson G, Powers MB, et al. Creating state of the art, next-generation
virtual reality exposure therapies for anxiety disorders using consumer hardware platforms: design considerations and future
directions. Cogn Behav Ther 2017 Sep;46(5):404-420. [doi: 10.1080/16506073.2017.1280843] [Medline: 28270059]
15. Pertaub DP, Slater M, Barker C. An experiment on public speaking anxiety in response to three different types of virtual
audience. Presence (Camb) 2002 Feb;11(1):68-78. [doi: 10.1162/105474602317343668]
16. Pertaub DP, Slater M, Barker C. An experiment on fear of public speaking in virtual reality. Stud Health Technol Inform
2001;81:372-378. [doi: 10.1162/105474602317343668] [Medline: 11317771]
17. Botella C, Baños RM, Perpiñá C, Villa H, Alcañiz M, Rey A. Virtual reality treatment of claustrophobia: a case report.
Behav Res Ther 1998 Feb;36(2):239-246. [doi: 10.1016/S0005-7967(97)10006-7] [Medline: 9613029]
18. Botella C, García-Palacios A, Villa H, Baños R, Quero S, Alcañiz M, et al. Virtual reality exposure in the treatment of
panic disorder and agoraphobia: a controlled study. Clin Psychol Psychother 2007;14:164-175. [doi: 10.1002/cpp.524]
19. Emmelkamp PM, Krijn M, Hulsbosch AM, de Vries S, Schuemie MJ, van der Mast CA. Virtual reality treatment versus
exposure in vivo: a comparative evaluation in acrophobia. Behav Res Ther 2002 May;40(5):509-516. [Medline: 12038644]
20. Moldovan R, David D. One session treatment of cognitive and behavioural therapy and virtual reality for social and specific
phobias. Preliminary results from a randomized clinical trial. J Cogn Behav Psychother 2014;14(1):67-83 [FREE Full text]
21. Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Effectiveness of computer-generated (virtual
reality) graded exposure in the treatment of acrophobia. Am J Psychiatry 1995 Apr;152(4):626-628. [doi:
10.1176/ajp.152.4.626] [Medline: 7694917]
22. Rothbaum BO, Hodges LF, Kooper R, Opdyke D, Williford JS, North M. Virtual reality graded exposure in the treatment
of acrophobia: a case report. Behavior Therapy 1995;26:547-554. [doi: 10.1016/S0005-7894(05)80100-5]
23. Rothbaum BO, Hodges L, Watson BA, Kessler CD, Opdyke D. Virtual reality exposure therapy in the treatment of fear of
flying: a case report. Behav Res Ther 1996;34(5-6):477-481. [Medline: 8687369]
24. Rothbaum BO, Hodges L, Smith S, Lee JH, Price L. A controlled study of virtual reality exposure therapy for the fear of
flying. J Consult Clin Psychol 2000 Dec;68(6):1020-1026. [doi: 10.1037/0022-006X.68.6.1020] [Medline: 11142535]
25. Rothbaum BO, Hodges L, Anderson PL, Price L, Smith S. Twelve-month follow-up of virtual reality and standard exposure
therapies for the fear of flying. J Consult Clin Psychol 2002 Apr;70(2):428-432. [doi: 10.1037/0022-006X.70.2.428]
[Medline: 11952201]
26. Rothbaum BO, Anderson P, Zimand E, Hodges L, Lang D, Wilson J. Virtual reality exposure therapy and standard (in
vivo) exposure therapy in the treatment of fear of flying. Behav Ther 2006 Mar;37(1):80-90. [doi: 10.1016/j.beth.2005.04.004]
[Medline: 16942963]
27. Shiban Y, Pauli P, Mühlberger A. Effect of multiple context exposure on renewal in spider phobia. Behav Res Ther 2013
Feb;51(2):68-74. [doi: 10.1016/j.brat.2012.10.007] [Medline: 23261707]
28. Whitney SL, Jacob RG, Sparto PJ, Olshansky EF, Detweiler-Shostak G, Brown EL, et al. Acrophobia and pathological
height vertigo: indications for vestibular physical therapy? Phys Ther 2005 May;85(5):443-458. [doi: 10.1093/ptj/85.5.443]
[Medline: 15842192]
29. Gerardi M, Rothbaum BO, Ressler K, Heekin M, Rizzo A. Virtual reality exposure therapy using a virtual Iraq: case report.
J Trauma Stress 2008 Apr;21(2):209-213 [FREE Full text] [doi: 10.1002/jts.20331] [Medline: 18404648]
30. Cárdenas-López G, de la Rosa A, Durón R, Durán X. Virtual reality exposure for trauma and stress-related disorders for
city violence crime victims. International Journal of Child Health and Human Development 2016;9(3):315-322.
31. McLay RN, Wood DP, Webb-Murphy JA, Spira JL, Wiederhold MD, Pyne JM, et al. A randomized, controlled trial of
virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related
post-traumatic stress disorder. Cyberpsychol Behav Soc Netw 2011 Apr;14(4):223-229. [doi: 10.1089/cyber.2011.0003]
[Medline: 21332375]
32. Reger GM, Holloway KM, Candy C, Rothbaum BO, Difede J, Rizzo AA, et al. Effectiveness of virtual reality exposure
therapy for active duty soldiers in a military mental health clinic. J Trauma Stress 2011 Feb;24(1):93-96. [doi:
10.1002/jts.20574] [Medline: 21294166]
33. Reger GM, Koenen-Woods P, Zetocha K, Smolenski DJ, Holloway KM, Rothbaum BO, et al. Randomized controlled trial
of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related
JMIR Serious Games 2018 | vol. 6 | iss. 4 | e10965 | p.10http://games.jmir.org/2018/4/e10965/
(page number not for citation purposes)
Oing & PrescottJMIR SERIOUS GAMES
XSL•FO
RenderX
posttraumatic stress disorder (PTSD). J Consult Clin Psychol 2016 Nov;84(11):946-959. [doi: 10.1037/ccp0000134]
[Medline: 27606699]
34. Cárdenas-López G, de la Rosa-Gómez A. Post-traumatic stress disorder treatment with virtual reality exposure for criminal
violence: A case study in assault with violence. Int J Child Health Hum Dev 2011;10(4):279-283. [doi:
10.1515/IJDHD.2011.061]
35. Rothbaum BO, Hodges L, Alarcon R, Ready D, Shahar F, Graap K, et al. Virtual reality exposure therapy for PTSD Vietnam
Veterans: a case study. J Trauma Stress 1999 Apr;12(2):263-271. [doi: 10.1023/A:1024772308758] [Medline: 10378165]
36. Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B, et al. A randomized, double-blind evaluation
of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and
Afghanistan War veterans. Am J Psychiatry 2014 Jun;171(6):640-648 [FREE Full text] [doi: 10.1176/appi.ajp.2014.13121625]
[Medline: 24743802]
37. Alsina-Jurnet I, Carvallo-Beciu C, Gutiérez-Maldonado J. Validity of virtual reality as a method of exposure in the treatment
of test anxiety. Behav Res Methods 2007 Nov;39(4):844-851. [Medline: 18183899]
38. Anderson P, Rothbaum B, Hodges LF. Virtual reality exposure in the treatment of social anxiety. Cogn Behav Pract
2003;10:240-247. [doi: 10.1016/S1077-7229(03)80036-6]
39. Harris SR, Kemmerling RL, North MM. Brief virtual reality therapy for public speaking anxiety. Cyberpsychol Behav 2002
Dec;5(6):543-550. [doi: 10.1089/109493102321018187] [Medline: 12556117]
40. Padrino-Barrios C, McCombs G, Diawara N, De Leo G. The use of immersive visualization for the control of dental anxiety
during oral debridement. J Dent Hyg 2015 Dec;89(6):372-377. [Medline: 26684994]
41. Repetto C, Gaggioli A, Pallavicini F, Cippresso P, Raspelli S, Riva G. Virtual reality and mobile phones in the treatment
of generalized anxiety disorders: a phase-2 clinical trial. Pers Ubiquitous Comput 2013;17(2):253-260. [doi:
10.1007/s00779-011-0467-0]
42. Tanja-Dijkstra K, Pahl S, White MP, Andrade J, Qian C, Bruce M, et al. Improving dental experiences by using virtual
reality distraction: a simulation study. PLoS One 2014;9(3):e91276 [FREE Full text] [doi: 10.1371/journal.pone.0091276]
[Medline: 24621518]
43. Wallach HS, Safir MP, Bar-Zvi M. Virtual reality cognitive behavior therapy for public speaking anxiety: a randomized
clinical trial. Behav Modif 2009 May;33(3):314-338. [doi: 10.1177/0145445509331926] [Medline: 19321811]
44. Fornells-Ambrojo M, Freeman D, Slater M, Swapp D, Antley A, Barker C. How do people with persecutory delusions
evaluate threat in a controlled social environment? A qualitative study using virtual reality. Behav Cogn Psychother 2015
Jan;43(1):89-107. [doi: 10.1017/S1352465813000830] [Medline: 24103196]
45. Freeman D, Antley A, Ehlers A, Dunn G, Thompson C, Vorontsova N, et al. The use of immersive virtual reality (VR) to
predict the occurrence 6 months later of paranoid thinking and posttraumatic stress symptoms assessed by self-report and
interviewer methods: a study of individuals who have been physically assaulted. Psychol Assess 2014 Sep;26(3):841-847
[FREE Full text] [doi: 10.1037/a0036240] [Medline: 24708073]
46. Freeman D, Pugh K, Antley A, Slater M, Bebbington P, Gittins M, et al. Virtual reality study of paranoid thinking in the
general population. Br J Psychiatry 2008 Apr;192(4):258-263 [FREE Full text] [doi: 10.1192/bjp.bp.107.044677] [Medline:
18378984]
47. Freeman D, Pugh K, Vorontsova N, Antley A, Slater M. Testing the continuum of delusional beliefs: an experimental study
using virtual reality. J Abnorm Psychol 2010 Feb;119(1):83-92 [FREE Full text] [doi: 10.1037/a0017514] [Medline:
20141245]
48. Cornwell BR, Johnson L, Berardi L, Grillon C. Anticipation of public speaking in virtual reality reveals a relationship
between trait social anxiety and startle reactivity. Biol Psychiatry 2006 Apr 01;59(7):664-666. [doi:
10.1016/j.biopsych.2005.09.015] [Medline: 16325155]
49. Geuss MN, McCardell MJ, Stefanucci JK. Fear similarly alters perceptual estimates of and actions over gaps. PLoS One
2016;11(7):e0158610 [FREE Full text] [doi: 10.1371/journal.pone.0158610] [Medline: 27389399]
50. Hartanto D, Kampmann IL, Morina N, Emmelkamp PG, Neerincx MA, Brinkman WP. Controlling social stress in virtual
reality environments. PLoS One 2014 Mar 26;9(3):e92804 [FREE Full text] [doi: 10.1371/journal.pone.0092804] [Medline:
24671006]
51. Orman EK. Effect of virtual reality graded exposure on heart rate and self-reported anxiety levels of performing saxophonists.
J Res Music Educ 2003;51(4):302-315. [doi: 10.2307/3345657]
52. Owens ME, Beidel DC. Can virtual reality effectively elicit distress associated with social anxiety disorder? J Psychopathol
Behav Assess 2015;37(2):296-305. [doi: 10.1007/s10862-014-9454-x]
53. Park IH, Kim J, Ku J, Jang HJ, Park S, Kim C, et al. Characteristics of social anxiety from virtual interpersonal interactions
in patients with schizophrenia. Psychiatry 2009;72(1):79-93. [doi: 10.1521/psyc.2009.72.1.79] [Medline: 19366296]
54. Powers MB, Briceno NF, Gresham R, Jouriles EN, Emmelkamp PM, Smits JA. Do conversations with virtual avatars
increase feelings of social anxiety? J Anxiety Disord 2013 May;27(4):398-403. [doi: 10.1016/j.janxdis.2013.03.003]
[Medline: 23746490]
JMIR Serious Games 2018 | vol. 6 | iss. 4 | e10965 | p.11http://games.jmir.org/2018/4/e10965/
(page number not for citation purposes)
Oing & PrescottJMIR SERIOUS GAMES
XSL•FO
RenderX
55. Price M, Mehta N, Tone EB, Anderson PL. Does engagement with exposure yield better outcomes? Components of presence
as a predictor of treatment response for virtual reality exposure therapy for social phobia. J Anxiety Disord 2011
Aug;25(6):763-770 [FREE Full text] [doi: 10.1016/j.janxdis.2011.03.004] [Medline: 21515027]
56. Qu C, Ling Y, Heynderickx I, Brinkman WP. Virtual bystanders in a language lesson: examining the effect of social
evaluation, vicarious experience, cognitive consistency and praising on students' beliefs, self-efficacy and anxiety in a
virtual reality environment. PLoS One 2015;10(4):e0125279 [FREE Full text] [doi: 10.1371/journal.pone.0125279] [Medline:
25884211]
57. Regenbrecht HT, Schubert TW, Friedmann F. Measuring the sense of presence and its relations to fear of heights in virtual
environments. Int J Hum Comput Interact 1998;10(3):233-249. [doi: 10.1207/s15327590ijhc1003_2]
58. Slater M, Pertaub DP, Barker C, Clark DM. An experimental study on fear of public speaking using a virtual environment.
Cyberpsychol Behav 2006 Oct;9(5):627-633. [doi: 10.1089/cpb.2006.9.627] [Medline: 17034333]
59. Veling W, Counotte J, Pot-Kolder R, van Os J, van der Gaag M. Childhood trauma, psychosis liability and social stress
reactivity: a virtual reality study. Psychol Med 2016 Dec;46(16):3339-3348. [doi: 10.1017/S0033291716002208] [Medline:
27619196]
60. Pluye P, Robert E, Cargo M, Bartlett G, O'Cathain A, Grifiths F, et al. Mixedmethodsappraisaltoolpublic.pbworks. 2011.
Proposal: a mixed methods appraisal tool for systematic mixed studies reviews URL: http://mixedmethodsappraisaltoolpublic.
pbworks.com/w/file/fetch/84371689/MMAT%202011%20criteria%20and%20tutorial%202011-06-29updated2014.08.21.
pdf [accessed 2018-10-10] [WebCite Cache ID 734K6xgys]
61. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Klauminzer G, Charney DS. A clinician rating scale for assessing
current and lifetime PTSD: The CAPS-1. Behav Ther 1995 Jan;8(1):75-90 [FREE Full text]
62. Cuijpers P, Schuurmans J. Self-help interventions for anxiety disorders: an overview. Curr Psychiatry Rep 2007
Aug;9(4):284-290. [doi: 10.1007/s11920-007-0034-6] [Medline: 17880859]
Abbreviations
ASD: acute stress disorder
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PTSD: posttraumatic stress disorder
RT: relaxation therapy
SCE: single context exposure
TAU: treatment as usual
VPT: vestibular physical therapy
VR: virtual reality
VRET: virtual reality exposure therapy
WL: waiting list
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